Severe Primary Immunodeficiency Disorder
Showing 1 - 25 of >10,000
Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in Graz (potential biomarkers)
Recruiting
- Immune Thrombocytopenia
- +3 more
- potential biomarkers
-
Graz, Styria, AustriaPediatric Hematology-Oncology Outpatient Clinic
Sep 8, 2022
Subcutaneous Immunoglobulin in Primary and Secondary
Not yet recruiting
- Primary Immune Deficiency Disorder
- Secondary Immune Deficiency
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jun 14, 2022
Primary Immune Deficiency Disorder Trial in United States (Bivigam, Other)
Active, not recruiting
- Primary Immune Deficiency Disorder
- Bivigam
- Other
-
Carpinteria, California
- +16 more
Jan 30, 2023
Primary Immunodeficiencies in Patients Hospitalized for Severe
Recruiting
- Primary Immunodeficiency
-
Montpellier, FranceUhmontpellier
Oct 11, 2021
Immunodeficiency Syndrome, Severe Aplastic Anemia, Genetic Disorder Trial in Nashville, Seattle (procedure, drug, other,
Terminated
- Immunodeficiency Syndrome
- +2 more
- Allogeneic Bone Marrow Transplantation
- +8 more
-
Nashville, Tennessee
- +2 more
Jan 6, 2021
Primary Immunodeficiencies in Patients Admitted for Severe
Recruiting
- Severe Infection
- Severe Immune Deficiency
-
Montpellier, FranceUhmontpellier
Oct 11, 2021
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Primary Immune Deficiency Disorder, Periodontitis Trial in London (Oral hygiene advice, non surgical periodontal treatment)
Completed
- Primary Immune Deficiency Disorder
- Periodontitis
- Oral hygiene advice, non surgical periodontal treatment
-
London, Greater London, United Kingdom
- +1 more
Nov 10, 2022
Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant
Recruiting
- Immune Deficiency Disorders
- +13 more
- Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
-
Saint Louis, MissouriWashington University
Apr 25, 2022
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)
Not yet recruiting
- Acute Lymphoblastic Leukemia in Remission
- +10 more
- CliniMACS
-
Houston, Texas
- +1 more
Dec 8, 2022
Immunologic Deficiency Syndromes Trial in Canada, United States (GC5107)
Completed
- Immunologic Deficiency Syndromes
- GC5107
-
Centennial, Colorado
- +19 more
Nov 11, 2022
HIV-1-infection, Cancer, Primary Immune Deficiency Disorder Trial in Darlinghurst, Sydney
Active, not recruiting
- HIV-1-infection
- +4 more
-
Darlinghurst, New South Wales, Australia
- +10 more
Aug 30, 2021
Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)
Recruiting
- Epstein-Barr Virus Infections
- Primary Immune Deficiency Disorder
- cytotoxic t-lymphocytes
-
Los Angeles, California
- +7 more
Sep 27, 2022
Cytomegalovirus Infections, Primary Immune Deficiency Disorder Trial in United States (viral specific cytotoxic t-lymphocytes)
Recruiting
- Cytomegalovirus Infections
- Primary Immune Deficiency Disorder
- viral specific cytotoxic t-lymphocytes
-
Los Angeles, California
- +7 more
Sep 27, 2022
Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)
Recruiting
- Adenovirus
- Primary Immune Deficiency Disorder
- cytotoxic t-lymphocytes
-
Los Angeles, California
- +8 more
Sep 27, 2022
Adult Patients With Immunodeficiency Within the Scope of the ICF
Recruiting
- Primary Immune Deficiency
- +3 more
-
Ankara, Hacettepe Unıversity, TurkeyEbru Çalık Kutukcu
Aug 23, 2023
Primary Immune Deficiency Disorder, Hematopoietic Stem Cell Transplantation Trial in Moscow (Biological: TCR alfa beta T cell
Completed
- Primary Immune Deficiency Disorder
- Hematopoietic Stem Cell Transplantation
- Biological: TCR alfa beta T cell depletion
-
Moscow, Russian FederationDmitry Rogachev Federal Research and Clinical Centre of Paediatr
Feb 9, 2021
Primary Immune Deficiency Disorder Trial (Immunoglobulin)
Withdrawn
- Primary Immune Deficiency Disorder
- Immunoglobulin
- (no location specified)
Jul 1, 2020
Complement Deficiency, Antibody Deficiency, Chronic Sinus Infection Trial in France (Immunological diagnosis tests)
Terminated
- Complement Deficiency
- +9 more
- Immunological diagnosis tests
-
Armentières, France
- +18 more
Sep 16, 2020
Non Infectious Presentation of Inborn Errors Of Immunity
Not yet recruiting
- Inborn Errors of Immunity
-
Sohag, EgyptSohag University Hospital
May 21, 2023
Primary Immune-Deficiency (PID) Common Variable Immune Deficiency (CVID) Trial in Strasbourg (FACS analyses, Target Sequencing
Completed
- Primary Immune-Deficiency (PID) Common Variable Immune Deficiency (CVID)
- FACS analyses
- +2 more
-
Strasbourg, FranceService d'Immunologie Clinique et VIH - Hôpital Civil
Feb 18, 2020
Primary Immune Deficiency Disorder Trial in Worldwide (octanorm 16.5%)
Completed
- Primary Immune Deficiency Disorder
- octanorm 16.5%
-
Birmingham, Alabama
- +23 more
Jul 26, 2021
Anxiety Trial in Nottingham (device, behavioral, other)
Completed
- Anxiety
- Alpha Stim AID cranial electrotherapy stimulation
- +7 more
-
Nottingham, Nottinghamshire, United KingdomLeicestershire and Rutland Improving Access to Psychological The
Jul 20, 2021
Severe Combined Immunodeficiency Disease, X-linked Trial in San Francisco, Memphis, Seattle (genetic, drug, device)
Recruiting
- Severe Combined Immunodeficiency Disease, X-linked
- CL20-i4-EF1α-hγc-OPT
- +2 more
-
San Francisco, California
- +2 more
Jan 9, 2023